Internal Medicine, Hematology · Stanford, CA
NPI
1568577906
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,073
26 services
Medicare patients, 2024
19
Average age 71
Drug cost, 2024
$4.0M
717 prescriptions
Company payments, 2025
$2,547
From 32 companies
Medicare prescription drug claims, 2024
In 2024, the drug Judy M Cheng prescribed most often to Medicare patients was Prednisone, with 48 prescriptions and refills. In total Judy M Cheng wrote 717 Medicare prescriptions that cost $4.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-05.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prednisone Generic | 48 | 62 | 12 | $240 |
| Anastrozole Generic | 46 | 121 | 16 | $672 |
| Abiraterone Acetate Generic | 45 | 50 | Under 11 | $189K |
| Imatinib Mesylate Generic | 42 | 44 | Under 11 | $78K |
| Revlimid Lenalidomide | 36 | 36 | Under 11 | $601K |
| Pomalyst Pomalidomide | 32 | 32 | Under 11 | $781K |
| Ondansetron Hcl Generic | 31 | 31 | 21 | $333 |
| Dexamethasone Generic | 29 | 29 | 18 | $208 |
| Hydroxyurea Generic | 25 | 63 | Under 11 | $497 |
| Jakafi Ruxolitinib Phosphate | 24 | 24 | Under 11 | $399K |
| Tagrisso Osimertinib Mesylate | 21 | 21 | Under 11 | $320K |
| Oxycodone Hcl Generic | 19 | 19 | 11 | $159 |
| Imbruvica Ibrutinib | 18 | 18 | Under 11 | $293K |
| Entecavir Generic | 14 | 39 | Under 11 | $3,205 |
| Olanzapine Generic | 14 | 14 | 11 | $67.24 |
Brand drugs: 244 claims; generic drugs: 473 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Judy M Cheng $2,547 ($2,547 in general payments such as food, travel and fees) from 32 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $446.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $446 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $225 |
| Janssen Biotech, Inc. JNJ | 7 | $190 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $137 |
| Celgene Corporation BMY | 3 | $126 |
| Organon LLC OGN | 1 | $110 |
| Abbvie Inc. ABBV | 3 | $87.94 |
| Merck Sharp & Dohme LLC MRK | 3 | $84.47 |
| Incyte Corporation INCY | 3 | $79.91 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $77.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.